Trial intelligence / Profile preview

RFA in metastatic renal cell carcinoma with small primary tumor

NCT00891475Phase 2Completed

Start
May 2008
Primary completion
Jan 2010
Modality
Cytokines & Interferons, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sunitinib, interferon alfa in renal cell carcinoma (RCC). Started May 2008; status: completed.

02

Drugs

sunitinibinterferon alfa
03

Conditions

renal cell carcinoma (RCC)

Beyond the preview

Go deeper on NCT00891475.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00891475.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call